Pharmacological inhibition of NF-κB and AP-1 signaling revealed their driving role in the early stages of fibrogenesis in the coculture model, suggesting that NF-κB and AP-1 signaling might also contribute to the pathobiological process in IPF and could be a potential target for pharmacological intervention. The gene discussed is FOS; the disease is idiopathic pulmonary fibrosis.